"A new consumer-friendly form ( is now available for making reports to MedWatch, the Food and Drug Administration's (FDA) on-line system for collecting information about serious problems with drugs, medical devices and other FDA-"...
- Patient Information:
Details with Side Effects
KALBITOR® (ecallantide) is indicated for treatment of acute attacks of hereditary angioedema (HAE) in patients 16 years of age and older.
DOSAGE AND ADMINISTRATION
The recommended dose of KALBITOR (ecallantide injection) is 30 mg (3 mL), administered subcutaneously in three 10 mg (1 mL) injections. If the attack persists, an additional dose of 30 mg may be administered within a 24 hour period.
KALBITOR (ecallantide injection) should only be administered by a healthcare professional with appropriate medical support to manage anaphylaxis and hereditary angioedema.
KALBITOR (ecallantide injection) should be refrigerated and protected from the light. KALBITOR (ecallantide injection) is a clear, colorless liquid; visually inspect each vial for particulate matter and discoloration prior to administration. If there is particulate matter or discoloration, the vial should not be used.
Using aseptic technique, withdraw 1 mL (10 mg) of KALBITOR (ecallantide injection) from the vial using a large bore needle. Change the needle on the syringe to a needle suitable for subcutaneous injection. The recommended needle size is 27 gauge. Inject KALBITOR (ecallantide injection) into the skin of the abdomen, thigh, or upper arm. Repeat the procedure for each of the 3 vials comprising the KALBITOR (ecallantide injection) dose. The injection site for each of the injections may be in the same or in different anatomic locations (abdomen, thigh, upper arm). There is no need for site rotation. Injection sites should be separated by at least 2 inches (5 cm) and away from the anatomical site of attack.
The same instructions apply to an additional dose administered within 24 hours. Different injection sites or the same anatomical location (as used for the first administration) may be used.
Dosage forms and Strengths
KALBITOR (ecallantide injection) is a clear, colorless liquid free of preservatives. Each vial of KALBITOR contains ecallantide at a concentration of 10 mg/mL.
Storage And Handling
KALBITOR (ecallantide) is supplied as three 10 mg/mL single-use vials packaged in a carton. Each vial contains 10 mg of ecallantide. Each vial contains a slight overfill.
NDC (47783-101-01): 3 single-use vials in 1 carton
KALBITOR (ecallantide injection) should be kept refrigerated (2°C to 8°C/36°F to 46°F). Vials removed from refrigeration should be stored below 86°F/30°C and used within 14 days or returned to refrigeration until use.
Protect vials from light until use.
Do not use beyond the expiration date.
Manufactured for: Dyax Corp., 300 Technology Square, Cambridge, MA 02139. November 27, 2009.
Last reviewed on RxList: 12/14/2009
This monograph has been modified to include the generic and brand name in many instances.
Additional Kalbitor Information
Report Problems to the Food and Drug Administration
You are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.
Find out what women really need.